Literature DB >> 11063980

Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study.

E L Moses1, W C Drevets, G Smith, C A Mathis, B N Kalro, M A Butters, M P Leondires, P J Greer, B Lopresti, T L Loucks, S L Berga.   

Abstract

BACKGROUND: Preclinical studies demonstrate that 17beta-estradiol (E(2)) increases serotonin-2A receptor (5-HT(2A)R) density in rat frontal cortex.
METHODS: We investigated the impact of hormone replacement therapy on 5-HT(2A)R binding potential (BP) using positron emission tomography and [(18)F]altanserin in five postmenopausal women. Subjects were imaged at baseline, following 8 to 14 weeks of transdermal E(2), 0.1 mg/d, and following 2 to 6 weeks of E(2) plus micronized progesterone (P) 100 mg per os twice daily. Regional BPs in the anterior cingulate cortex, dorsolateral prefrontal cortex, and lateral orbitofrontal cortex were calculated by Logan analysis.
RESULTS: There was a main effect of time (p = .017) for 5-HT(2A)R BP, which increased 21.2%+/-2.6% following combined E(2) and P administration relative to baseline. This effect was evident in all cerebral cortex regions examined.
CONCLUSIONS: 5-HT(2A)R BP increased in widespread areas of the cerebral cortex following combined E(2) + P administration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063980     DOI: 10.1016/s0006-3223(00)00967-7

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  34 in total

Review 1.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

Review 2.  [The effects of hormone replacement therapy on mind and brain].

Authors:  P Baldinger; G Kranz; A Höflich; M Savli; P Stein; R Lanzenberger; S Kasper
Journal:  Nervenarzt       Date:  2013-01       Impact factor: 1.214

3.  Enhanced neuroactivation during verbal memory processing in postmenopausal women receiving short-term hormone therapy.

Authors:  Carol C Persad; Jon-Kar Zubieta; Tiffany Love; Heng Wang; Anne Tkaczyk; Yolanda R Smith
Journal:  Fertil Steril       Date:  2008-08-09       Impact factor: 7.329

4.  Medial prefrontal cortex 5-HT(2A) density is correlated with amygdala reactivity, response habituation, and functional coupling.

Authors:  Patrick M Fisher; Carolyn C Meltzer; Julie C Price; Rhaven L Coleman; Scott K Ziolko; Carl Becker; Eydie L Moses-Kolko; Sarah L Berga; Ahmad R Hariri
Journal:  Cereb Cortex       Date:  2009-03-25       Impact factor: 5.357

5.  Gender, personality, and serotonin-2A receptor binding in healthy subjects.

Authors:  Paul H Soloff; Julie C Price; Neale Scott Mason; Carl Becker; Carolyn C Meltzer
Journal:  Psychiatry Res       Date:  2010-01-30       Impact factor: 3.222

6.  Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder.

Authors:  Paul H Soloff; Laurel Chiappetta; Neale Scott Mason; Carl Becker; Julie C Price
Journal:  Psychiatry Res       Date:  2014-03-29       Impact factor: 3.222

Review 7.  Estrogen and the prefrontal cortex: towards a new understanding of estrogen's effects on executive functions in the menopause transition.

Authors:  Sheila Shanmugan; C Neill Epperson
Journal:  Hum Brain Mapp       Date:  2012-12-14       Impact factor: 5.038

8.  Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging.

Authors:  Yolanda R Smith; Tiffany Love; Carol C Persad; Anne Tkaczyk; Thomas E Nichols; Jon-Kar Zubieta
Journal:  J Clin Endocrinol Metab       Date:  2006-08-15       Impact factor: 5.958

Review 9.  Sex hormones and mood in the perimenopause.

Authors:  Peter J Schmidt; David R Rubinow
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

10.  Differences in free estradiol and sex hormone-binding globulin in women with and without premenstrual dysphoric disorder.

Authors:  Susan Thys-Jacobs; Don McMahon; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2007-10-23       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.